Exclusive Summary

• Sodium hyaluronate eye drops have a robust global market propelled by high dry eye disease prevalence, WHO essential medicine listing, and first-line treatment recommendations in multiple guidelines.
• Original patents have widely expired, opening the market to numerous generics, yet opportunities remain for high-quality, compliant products, particularly in regions valuing strict standards.
• Chinese suppliers leverage significant cost advantages through economies of scale, coupled with international certifications and extensive registration experience, to offer high-value, compliant products.
• Immense therapeutic demand for dry eye disease and post-surgical recovery ensures strong and sustained market demand for sodium hyaluronate as a safe and effective lubricant.